Back
Back
EBS-101-CL-001
Official Title
A Multicenter, Placebo-Controlled, Double-Blind, Randomized, Parallel-Group, Phase 2b Study to Evaluate the Efficacy and Safety of Ecopipam Tablets in Children and Adolescent Subjects with Tourette's Syndrome
Study Details
This research study will examine the efficacy and safety of ecopipam in pediatric patients with Tourette's Syndrome (TS).
Principal Investigator
Dr. Kevin Black
IRB Number
201907022
Eligibility
1. Participants must be 6 to 17 years of age at the time of screening
2. Participants must have Tourette's Syndrome
3. Participants must exhibit both motor and vocal tics
Volunteer Information
For more information about this study, contact Volunteer for Health at:
- 314.362.1000
- rprstaff@wustl.edu